QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.

Press

28Oct 2026

Five posters. Five important research questions. The power of Nordic real-world data.

At ISPOR Europe 2026, Quantify Research colleagues will present collaborative research demonstrating how Nordic national registers can inform healthcare decision-making.

The research spans treatment patterns, treatment persistence, and the economic and societal burden of disease across several therapeutic areas.

📊 Here‘s where you can find our research in Vienna:

📅 Monday 9 November   | 🕥 10:30 – […]

26Oct 2026

📊EQ-5D-5L: Does the choice of value set influence cost-effectiveness conclusions

How health-related quality of life is valued can have important implications for QALY calculations, cost-effectiveness assessments, and ultimately, reimbursement decisions.

A new report from the Health Economics and Policy research group at Karolinska Institutet, commissioned by the Tandvårds- och läkemedelsförmånsverket, TLV examines this question.

Building on previous research, the report systematically compares newly developed Swedish, Nordic, and UK EQ-5D-5L […]

25Oct 2026

Meet Quantify Research at ISPOR Europe 2026!

We’re looking forward to joining colleagues from across the HEOR community in Vienna, 8–11 November.

Together with our colleagues from the athagoras Group, you’ll find us at Booth #810.

Our CEO, Kirk Geale, PhD, will be particularly active at this year’s conference. Alongside his role on the ISPOR Program Committee, Kirk serves as Co-Chair of the […]

19Oct 2026

Some days are just a little more special than others🦌

Quantify Research Denmark has been named a Børsen Gazelle 2026!
We are delighted, humbled, and proud to receive this recognition from Børsen.

This recognition reflects the dedication of our team and the trust our clients have placed in us over the past four years.

A heartfelt thank you to our colleagues, clients, and partners who have been part of this journey.

We look forward […]